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Key points
 We have developed novel techniques for paired, direct, real-time in vivo quantification of
endothelial glycocalyx structure and associated microvessel permeability.
 Commonly used imaging and analysis techniques yieldmeasurements of endothelial glycocalyx
depth that vary by over an order of magnitude within the same vessel.
 The anatomical distancebetweenmaximal glycocalyx label andmaximal endothelial cell plasma
membrane label provides the most sensitive and reliable measure of endothelial glycocalyx
depth.
 Sialic acid residues of the endothelial glycocalyx regulate glycocalyx structure and microvessel
permeability to both water and albumin.
Abstract The endothelial glycocalyx forms a continuous coat over the luminal surface of all
vessels, and regulates multiple vascular functions. The contribution of individual components of
the endothelial glycocalyx to one critical vascular function, microvascular permeability, remains
unclear. We developed novel, real-time, paired methodologies to study the contribution of sialic
acids within the endothelial glycocalyx to the structural and functional permeability properties
of the same microvessel in vivo. Single perfused rat mesenteric microvessels were perfused
with fluorescent endothelial cell membrane and glycocalyx labels, and imaged with confocal
microscopy. A broad range of glycocalyx depth measurements (0.17–3.02 μm) were obtained
with different labels, imaging techniques and analysis methods. The distance between peak
cell membrane and peak glycocalyx label provided the most reliable measure of endothelial
glycocalyx anatomy, correlating with paired, numerically smaller values of endothelial glycocalyx
depth (0.078 ± 0.016 μm) from electron micrographs of the same portion of the same vessel.
Disruption of sialic acid residueswithin the endothelial glycocalyx using neuraminidase perfusion
decreased endothelial glycocalyx depth and increased apparent solute permeability to albumin in
the samevessels in a time-dependentmanner,with changes in all three true vesselwall permeability
coefficients (hydraulic conductivity, reflection coefficient anddiffusive solutepermeability).These
novel technologies expand the range of techniques that permit direct studies of the structure of
the endothelial glycocalyx and dependent microvascular functions in vivo, and demonstrate
that sialic acid residues within the endothelial glycocalyx are critical regulators of microvascular
permeability to both water and albumin.
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Introduction
The entire luminal surface of all vascular walls is
covered with a continuous, carbohydrate-rich mesh: the
endothelial glycocalyx (Weinbaum et al. 2007). The
membrane-bound portion of the endothelial glycocalyx
is supplemented with components of plasma to form
a thickened endothelial surface layer. This endothelial
coat governs the nature of interactions between fluid,
protein and cellular constituents of flowing blood and
the endothelial cell, and is therefore a critical regulator
of vascular function (Curry & Adamson, 2013). The
endothelial glycocalyx regulates permeability in exchange
microvessels; leukocyte rolling, adhesion andmigration in
post-capillary venules; mechanotransduction, flow- and
shear-induced vasodilatation in arterioles; and protects
the vessel wall from the development of atherosclerosis in
conduit arteries.
The role of the endothelial glycocalyx in regulating
microvessel permeability was formalised in the
fibre-matrix junction-break theory proposed by Curry
and Michel in 1980. This theory and subsequent
refinements hold that the endothelial glycocalyx is the
primary macromolecular sieve in continuous micro-
vessels, and that this sieving immediately above inter-
endothelial junctions creates a protected ‘sub-glycocalyx
space’, whose oncotic pressure determines the magnitude
of the oncotic pressure gradient resisting water and
solute flux across vessel walls (Levick & Michel, 2010).
Demonstrations of the resulting non-linear form of the
Starling equation under steady-state filtration conditions
(Michel & Phillips, 1987), and unequal actions of luminal
and abluminal oncotic pressures (Hu et al. 2000),
support this theory. These functional demonstrations are
supported by recent observations that a repeating periodic
arrangement of the fibres of the endothelial glycocalyx are
sufficient to explain the near-uniform macromolecular
permeability coefficients seen throughout the vasculature
(Squire et al. 2001; Arkill et al. 2011). The endothelial
glycocalyx also regulates hydraulic resistance, with greater
glycocalyx depths providing greater resistance (Adamson,
1990; Salmon et al. 2009).
The structure of the endothelial glycocalyx is complex,
with depth, spatial localisation and 3-D architecture
all structural facets that impact on vascular function,
including permeability. In addition, determining
the relative functional importance of different
glycocalyx components has been challenging. The
endothelial glycocalyx contains an array of glycoproteins,
proteoglycans and glycosaminoglycans (GAGs), with
much focus on the importance of GAGs in regulating
key physiological properties to the vessel wall (Tarbell &
Ebong, 2008). Many of the glycoproteins are capped by
sialic acid (Varki, 2008) contributing to the structure of
the glycocalyx. The dominant GAG is heparan sulphate,
which is a family of charged molecules with a wide variety
of subtypes depending on the nature of bonds between
individual saccharide units and their sulphation pattern
(Weinbaum et al. 2007). Heparan sulphate has been
shown to regulate mechanotransduction (Florian, 2003;
Kumagai et al. 2009), and evidence indicates an important
role in regulating permeability in endothelial monolayers
in vitro (Singh et al. 2007) and in isolated coronary
arterioles ex vivo (Huxley &Williams, 2000). Chondroitin
sulphate also carries significant charge, and again appears
to have an important role in regulating permeability
(Jeansson & Haraldsson, 2003). Finally hyaluronan, a
non-sulphatedGAGwith extended chain length, also plays
important roles in mechanotransduction and glomerular
filtration (Jeansson et al. 2006, 2009; Pahakis et al. 2007).
At present, little is known about the potential role
that sialic acid residues within the endothelial glycocalyx
may alsomake tomicrovessel permeability characteristics.
Sialic acid residues regulate leukocyte (Sakarya et al. 2004)
and platelet (Gorog et al. 1982) adhesion, mechano-
transduction (Tarbell & Ebong, 2008; Kumagai et al.
2009), low-density lipoprotein (LDL) uptake into end-
othelial cells (Gorog et al. 1982) and development
of atherosclerosis (Cuniberti et al. 2005). Endothelial
glycocalyx sialic acid residues are disrupted in disease
states predisposing to atherosclerosis such as diabetes
(Nassimizadeh et al. 2010), as well as playing an important
role in kidney disease (Dekan et al. 1991; Gelberg et al.
1996), and sepsis (Adembri et al. 2011), all of which have
been linked to endothelial glycocalyx dysfunction (Salmon
& Satchell, 2012). Despite this, the role of sialic acids in
regulatingmicrovessel permeability remains unclear. Early
studies showed no change in microvessel permeability
following sialic acid disruption by neuraminidase (Mason
et al. 1977). In vitro studies indicate a role for sialic acid
residues in endothelial cell monolayer barrier function
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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(Singh et al. 2007; Cioffi et al. 2012), but the endothelial
glycocalyx and permeability coefficients of cultured end-
othelial cells are substantially different from the in vivo
situation (Curry, 2005; Chappell et al. 2009). Despite
their abundance and importance in key physiological
processes and disease states, the importance of endothelial
glycocalyx sialic acid residues in regulating intact vessel
wall permeability coefficients remains unclear.
Current in vivo studies of the endothelial glycocalyx
either involve disruptive (e.g. electron microscopy) or
indirect (e.g. tracer exclusion) techniques to examine the
endothelial glycocalyx, both of which give conflicting
results (Salmon et al. 2009; Gao & Lipowsky, 2010).
Newer and more direct optical imaging techniques which
have employed the use of fluorescently tagged anti-
bodies and lectins to bind glycocalyx have also been
attempted in recent years (Cai et al. 2012; Salmon et al.
2012; Yen et al. 2012). These techniques have often used
confocal laser scanning and two-photon microscopes in
an attempt to better resolve the glycocalyx in micro-
vessels. However, even with the improved resolution
of laser scanning methods, these optical techniques are
still assessing changes in glycocalyx structure that fall
within or below the diffraction limit of optical imaging,
particularly in the physiological environment (Gretz &
Duling, 1995). To make estimates of relative changes in
depth within this resolution limit, each of these direct
optical imaging techniques have applied different analysis
methods which often yield varying and conflicting results
(Gao & Lipowsky, 2010; Cai et al. 2012; Salmon et al.
2012; Yen et al. 2012). In addition, these studies of end-
othelial glycocalyx are rarely coupled with measurements
of the functional properties of the wall of the same
vessel.
The aim of this study was to understand the
contribution of endothelial glycocalyx sialic acid residues
to microvascular structure and permeability function,
and to do so we have developed methods for real-time,
direct, paired measurements of endothelial glycocalyx
structure and function in vivo, as well as applying electron
microscopy preservation to compare in vivo and ex vivo
measurements of the same vessels with known functional
properties.
Methods
Ethical approval. Procedures were carried out in
accordance with national regulations set out by the UK
Home Office legislation, and with local approval from
the University of Bristol local ethical committee. Male
Sprague–Dawley rats (150–250 g; Harlan, Oxon, UK)
were used in all experiments. Anaesthesia was induced
with an intraperitoneal injection of sodium pentobarbital
(60 mg kg−1), and maintained with subcutaneous intra-
muscular injections approximately every 45 min. At
the end of all experiments animals were killed with
excess anaesthetic and cervical dislocation. Glycocalyx
measurements were made on 16 rats, solute permeability
measurements on 9 rats, and hydraulic conductivity and
reflection coefficient measurements on 7 rats.
Real-time endothelial glycocalyx imaging. Under
anaesthesia, the mesentery was exposed via a midline
laparotomy, constantly superfused with mammalian
Ringer solution at 37°C, teased over a glass coverslip,
and imaged via the objective of an inverted micro-
scope. Capillaries and post-capillary venules from 10
to 40 μm in diameter and without rolling or adherent
leukocytes were identified and cannulated in the direction
of flow with a refillable bevelled glass micropipette
(Bates et al. 2002) for endothelial glycocalyx imaging
alone in initial experiments. Microvessels were then
perfused continuously with mammalian Ringer solution
containing bovine serum albumin (BSA; 4%; A4378,
Sigma, Dorset, UK), followed by supplementation with
an endothelial cell membrane label (octadecyl rhodamine
B chloride (R18); 2 μM in BSA–Ringer–0.01% DMSO;
O246, Life Technologies, Renfrew, UK), or TMA-DPH (1-
(4-trimethylammoniophenyl)-6-phenyl-1,3,5-hexatriene
p-toluenesulfonate; 2 μM in BSA–Ringer–0.01% DMSO;
T204, Molecular Probes, Eugene, OR, USA) (Peti-Peterdi
et al. 2009) and then labelling of sialic acid residues within
the endothelial glycocalyx (fluorescein isothiocyanate
(FITC)-conjugated wheat germ agglutinin (WGA;
2 mol mol−1 dye content; 2.77 μM in BSA–Ringer;
L4895, Sigma) or trimethylrhodamineisothiocyanate
(TRITC)-conjugated WGA (0.65 mol mol−1 dye
content; 11.08 μM in BSA–Ringer; L5266, Sigma), with
concentrations determined in preliminary optimisation
experiments, each for 5 min, followed by washout with
unsupplemented 4% BSA–Ringer solution.
Respiratory and peristaltic movement required both
fluorophores (R18 and FITC-WGA) to be excited
and detected simultaneously in all experiments. The
consequent theoretical possibility of signal detection in
the 605 ± 75 nm (R18) channel from the broad emission
spectrum of WGA-conjugated FITC was assessed
qualitatively and quantitatively. Fluorescein (FITC-WGA)
artefacts observed in the centre of vessels were detected
in both the 515 ± 30 nm (FITC) and 605 ± 75 nm (R18)
channels. Due to simultaneous dual colour fluorescence
collection overlap of the R18 emission with the 488
laser can be significant therefore other fluorophores
used in combined glycocalyx–permeability studies
(FITC-WGA and Alexa Fluor 488 (Alexa 488) BSA)
also required assessment of alternative glycocalyx and
endothelial cell membrane labels. Endothelial glycocalyx
depth was therefore also measured using TRITC-WGA
(to label sialic acid residues in the endothelial glycocalyx),
and TMA-DPH (to label endothelial cell membrane),
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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with neither fluorophore emission spectra detectable by
an alternative channel. This combination of TMA-DPH
(endothelial cell membrane) and TRITC-WGA (sialic acid
residues in the endothelial glycocalyx) also eliminated
the possibility of fluorescence emission from anatomical
labels from confounding the functional solute flux data
obtained using Alexa 488 BSA in later experiments.
Labelled mesenteric microvessels were imaged via the
objective (CFI Plan Apochromatic VC 60× Oil with
1.4 NA) of an inverted microscope (Nikon Eclipse TiE),
and scanned in the x and y directions using 488 nm and
543.3 nm wavelength lasers (100% laser power). The laser
power, gain and offset for both channels was kept constant
for all experiments (515 ± 30 nm channel = 90 gain
and 0 offset; 605 ± 75 nm = 100 gain and 0 offset).
Fluorescent light emitted back into the objective was
detected using 515 ± 30 nm and 605 ± 75 nm photo-
multiplier tubes (PMTs), and differential interference
contrast (DIC) images were detected simultaneously in
a diascopic manner using a PMT for transmitted light.
z-stack images (2048 by 2048 pixels; 20 slices) were
captured through the entire vessel using an even inter-slice
distance in proportion to the height of the vessel being
imaged (e.g. a 20 μm diameter vessel will have 20 optical
slices each 1 μm apart) (Fig. 1A).
Endothelial glycocalyx image analysis. All z-stacks were
analysed using FIJI (Image J) software (Schindelin et al.
2012). Three channels (DIC, endothelial glycocalyx label
(FITC or TRITC), and cell membrane label (R18 or
0
0
4
12
8
16
20
ED
C
A B35.00 μm
30.00 μm
25.00 μm
20.00 μm
15.00 μm
10.00 μm
5.00 μm
0.00 μm
Intensity
(If)
180
160
140
120
100
80
60
40
20
0 0.5 1.0 1.5
μm
2.0 2.5 3.0
25 μm
P-P
FWHM
1 2 3 4 5 6 7 8
position across model (pixels)
l f
Figure 1. Imaging and analysis of endothelial
glycocalyx in vivo
A, section of a z-stack imaged in vivo; when a
measurement line was drawn across the width of a
vessel, all available slices (blue arrows) were
scanned though and the slice which yielded the
widest vessel diameter (red arrow) was selected for
measurements. B, example of FITC-WGA (green)
and R18 (red) imaged vessel in the mid-plane
region. For demonstration purposes the intensity
profile (yellow arrow) has only been drawn on one
side of the vessel; this line was actually drawn across
the entire width and therefore took measurements
of both sides simultaneously. C, the intensity profile
of both R18 and FITC-WGA along a line across the
vessel wall (yellow arrow) was used to determine 4
parameters of glycocalyx depth: (1) the anatomical
distance between peak signals from R18 and
FITC-WGA labels (peak to peak: P-P) as a measure
of depth, (2) the full width measured at the point of
half-maximal fluorescence intensity of FITC-WGA
(FWHM) and (3) the peak intensity of FITC-WGA (If),
and (4) fractional coverage of endothelial glycocalyx
was calculated as the number of points with a peak
to peak endothelial glycocalyx depth measurement
>0. D, a model of endothelial glycocalyx (green bar)
was moved (white arrow) at 1 nm intervals across
an Airy disc representation of laser light (white
circle). Scale bar: 100 nm. E, the fluorescence
intensity (If) of measurements across the green bar
(green points) was highest when peak If was
calculated by triangulation (interrupted straight blue
lines, blue arrows), lowest from absolute values
(green points and arrows), and intermediate when
peak If was calculated from a Gaussian distributions
(interrupted black curve, black arrows).
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TMA-DPH channels)) and 20 slices in the z plane
were processed to account for variability in the image
acquisition step, predominantly arising from respiratory
and peristaltic movement between optical slices of the
z-stacks causing misalignment of frames within a z-stack.
Virtual stack slices were therefore registered based on
the images acquired in the DIC channel, and realigned
identically for all channels to generate a 3-D image
of the entire vessel. Once registered, the z-stack image
demonstrating the maximal vessel diameter (i.e. the
mid-point of the vessel, and the position in which
endothelial glycocalyx and cell membrane labels will
be perpendicular to the plane of section, minimising
anatomical overlap) was identified (Fig. 1A, red arrow).
Fluorescence intensity profiles were then generated for
both endothelial cell label and the sialic acid component
of the endothelial glycocalyx label, along 30 evenly-spaced
lines across the full width of the vessel. Each point
along the profile represented the average fluorescence
intensity from 16 adjacent pixels (8 pixels either side of
the line drawn) (Fig. 1B). Four automated measurements
of endothelial glycocalyx parameters were then calculated
(Fig. 1C): (i) the anatomical distance between peak
signal intensity of the endothelial cell membrane label
and sialic acid component of the endothelial glycocalyx
label (‘peak to peak’); (ii) the full width measured at
the point of half-maximal fluorescence intensity of the
sialic acid component of the endothelial glycocalyx label
(‘FWHM’); (iii) thepeakfluorescence intensity of the sialic
acid component of the endothelial glycocalyx label (If);
and (iv) fractional coverage of positively (and negatively)
resolvable glycocalyx.Meanvalues for eachof thefirst three
assessments of the endothelial glycocalyxwere determined
using data from all of the 30 intensity lines analysed;
any values for peak to peak which yielded depth values
of 0 were excluded from the calculation of the mean
glycocalyx depth and were used to determine (iv). All
registration, maximal width identification, fluorescence
intensity profiling andmeasurement stepswere conducted
by automated macros.
To model whether the peak to peak method was
dependent on the size of the individual picture elements
acquired in the image we used computational modelling
to vary the anatomical position of the ‘true’ theoretical
peak glycocalyx within a single voxel by passing an
Airy disc representation of 488 nm laser light passing
through a 1.4 NA objective (Fig. 1D) at 1 nm inter-
vals. The anatomical position of the maximum intensity
reading would vary as much as one voxel integer
(104 nm for the 60× objective). This problem was
addressed mathematically by comparing the recorded
peak intensity with those calculated to be close to the
true intensity via linear interpolation (triangulation)
and Gaussian fitting of the three peak pixels recorded
(Fig. 1E). Results showed that recorded peak intensities
and triangulated peak intensities varied depending on
the true position, but Gaussian intensities provided the
least variable (mid-range) results, with the position of
peak fluorescence intensity identified independent of the
starting point of the scan, therefore providing the greatest
anatomical resolution of these threemethods. (Fig. 1E). As
a consequence, all further measurements were calculated
using the peak value of a Gaussian fit of recorded peak
intensities.
Paired imaging of solute flux and endothelial glycocalyx.
Having developed imaging methods for studying the
endothelial glycocalyx in real time in vivo, alternative
cannulation and perfusion systems were necessary and
hence developed for combined solute permeability and
endothelial glycocalyx imaging (Fig. 2A). Micropipettes
were constructed in-house from split-barrel borosilicate
glass capillaries (o.d. 2mm, wall thickness 0.3mm, central
septum thickness 0.22mm), pulled to a fine tip (Narishige
P22), bevelled (25 deg angle, 10–15 μm tip diameter),
and angled mid-shaft (45 deg angle). Each pipette
barrel then received a refilling line (stretched polyethylene
tubing, o.d. 0.61 mm) and a blunt-tipped needle (26G),
before the non-cannulating rear aperture was sealed with
epoxy resin. The refill line was connected to a syringe
pump-driven replaceable refill reservoir for exchanging
solutions within each pipette barrel; the 26G needles were
attached to individual, modifiable water manometers to
control hydrostatic pressures in each side of the pipette
independently (Fig. 2A).
Using the same surgical preparation described above
for glycocalyx-only imaging, mesenteric microvessels
were cannulated using this double-barrelled pipette
system. Barrel A contained BSA–Ringer solution (final
concentration 4% w/v BSA). Barrel B contained BSA–
Ringer solution supplemented with Alexa Fluor 488-
conjugated BSA (Alexa 488 BSA; 0.03 mg ml−1 unless
otherwise stated) to a final concentration of 4% w/v
total BSA. Following cannulation, the pressures exerted
individually tobothpipettebarrelswere adjustedmanually
using the relevant water manometers until balance
pressure was reached (perfusion ceased; typical range
15–25 cmH2O). The pressure in barrel A (BSA–Ringer)
was then marginally raised (1–5 cmH2O) above the
pressure in barrel B (Alexa 488 BSA) until the vessel was
perfused with BSA–Ringer solution only, without back-
flow into barrel B. The vessel was continuously perfused
under these stable conditions for 10 min before image
acquisition.
The entire imagingwindowwas excited at 480 nmusing
awidefieldfluorescent light-emittingdiode (LED) (Precise
Excite Cool LED; 50% power). Emitted fluorescence
was filtered through a 535 nm filter block and focused
onto the sensor of a high sensitivity camera (Photo-
metricsCoolSnapHQ2; fixed settings: 14 bitmonochrome
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 2. Paired imaging of solute permeability and endothelial glycocalyx in single microvessels
A, two 26G needles (n) and two fine tubes (grey line) were inserted into each of the main barrels of the bevelled
theta-style micropipette (tp) and glued in place to form a tight seal. Two syringe pumps (sp) were used to push
solution into the fine tube which was connected to the pump by a refill line (r) and both sides filled with BSA–Ringer
solution (or desired dye). The other end of the syringe pumps (sp) were connected to a waste line (w) that was
positioned directly behind the back of the two needles (n) and would pull solution away (green arrows) as the
refill line pushed solution into (black arrows) the pipette. The needles were also connected to two separate
water manometers; the right manometer (rm) and the left manometer (lm) to control pressure on each side of
the pipette independently. This design allowed the solution in the pipette to be readily changed even during
microvessel cannulation. B, mesenteric microvessels of pentobarbitone-anaesthetised male Sprague–Dawley rats
were cannulated using theta-style micropipettes where the pressure on either side was set so that only one desired
side perfused (15–30 cmH2O). Perfused BSA–Ringer solution was switched instantly to perfused Alexa 488-labelled
BSA (0.03 mg ml−1) transiently for 30–60 s, and imaged using fluorescence microscopy. C, a measuring window
is drawn across the vessel and areas surrounding it and the change in mean fluorescence intensity (If) is plotted
against time (t). Initial filling of the vessel with Alexa 488-labelled BSA causes a stepwise increase in If (If0),
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followed by a steady linear increase in If, the initial rate of change of which ([dIf/dt]0) represents the rate of
solute flux across the vessel wall. D, confocal image of cannulated mesenteric microvessel perfused and labelled
with TMA-DPH (endothelial cell membrane: blue) and TRITC-WGA (sialic acids within endothelial glycocalyx: red).
vl: vessel lumen; int: interstitium. White bar: selected line of interest across vessel wall. E, fluorescence intensity
profile along selected white bar. P-P (peak to peak): measure of anatomical distance between peak fluorescence of
TMA-DPH (endothelial cell membrane: blue) and TRITC-WGA (sialic acids within endothelial glycocalyx: red) signals.
FWHM: measure of full-width half-maximum of TRITC-WGA (sialic acids within endothelial glycocalyx: red) signal.
Other previously described parameters were also analysed (mean peak If of TRITC-WGA, and fractional coverage).
F, representative images of the same cannulated and perfused microvessel imaged using light (a), confocal (b)
and electron (c) microscopy. Fa, P: pipette; I: interstitium; VL: vessel lumen. Fb, red: endothelial cell membrane
(R18); green: endothelial glycocalyx (FITC-WGA); white box: portion of membrane also examined by electron
microscopy. Fc, VL: vessel lumen; EG: endothelial glycocalyx; ECM: endothelial cell membrane; EC: endothelial cell;
I: interstitium.
detection; 20 MHz readout mode; 2 × 2 binning; 696 ×
520 pixels; 350 visual gain). Under these conditions, initial
videoswere captured (NikonNISElements software; 60ms
intervals; 20 s duration). Pressures in barrels A and B were
then instantly swapped, halting perfusion of BSA–Ringer
solution and commencing perfusion with Alexa 488 BSA
(Fig. 2B and C). After 20 s perfusion with fluorescent
solution, pressures were switched back to initial settings,
generating perfusion with non-fluorescent BSA–Ringer
for a final period of 20 s (Fig. 2C). This perfusion
and imaging sequence for capturing solute permeability
(PsBSA) quantification datawas repeated 4–5 times for each
period of the experiment. During these experimental peri-
ods, perfusate either contained vehicle, or neuraminidase
to disrupt sialic acids (neuraminidase from Clostridium
perfringens, Salmon et al. 2012; 2 U ml−1 in 4% BSA;
N2876, Sigma).
Following this imaging of solute flux, pipette barrels
A and B were refilled and the vessel perfused with labels
for endothelial cell membrane and glycocalyx: note that
the use of Alexa 488-labelled BSA precluded the use of
overlapping emission fluorophores (e.g. FITC) for cell
membrane or glycocalyx labelling in these permeability
experiments. After PsBSA measurements, vessels were
therefore labelled with TMA-DPH to label endothelial
cell membranes; and TRITC-WGA to label endothelial
glycocalyx sialic acid residues; Fig. 2D). Each dye was
perfused for 5 min, before lumen refill and perfusion with
BSA–Ringer solution alone. Endothelial glycocalyx was
then imaged as described above (Fig. 2E).
Solute permeability analysis. Real-time video images of
Alexa 488 BSA-perfused microvessels were analysed using
Nikon NIS Elements software. A standard region of
interest (ROI) was created covering the full length of
the perfused vessel in the imaging field and extending
20 μm directly adjacent to either side of the vessel,
with the distance between pipette tip and the ROI
position maintained at 150 μm. ROI measurements of
mean fluorescence intensity (If) vs. time (seconds) were
recorded from each experiment and plotted as a scatter
plot giving a characteristic time course appearance (e.g.
Fig. 2C). Anatomical dimensions of the microvessel radii
(r) were measured directly from images of endothelial cell
membrane labelling in the same microvessel.
A typical time course plot (e.g. Fig. 2C) demonstrated a
steady baseline value of background fluorescence intensity
(If) during perfusion of BSA–Ringer alone. Initial filling
of the vessel lumen with Alexa 488 BSA caused a sharp,
stepwise increase in fluorescence intensity (If; [If]0)).
Initial BSA transport across the vessel wall caused a steady
rate increase in If over time ([dIf/dt]0) (Fig. 2C; white line),
followed by a sudden drop in If when the perfusate was
switched back to BSA–Ringer solution.
The permeability coefficient of the solute BSA (PsBSA)
was the rate of flux of BSA (JsBSA) through an area of a
microvessel (A) per unit concentration difference (c).
This can be expressed as:
P sBSA = J sBSA
A
× 1
c
(1)
With this methodology (Huxley et al. 1987), JsBSA could
be calculated from the initial stepwise change (If) and
subsequent rate of change in fluorescence intensity (dIf)
over time (t) immediately (time zero: ‘0’) after the capillary
lumen was filled with Alexa 488 BSA in a capillary of
measured radius (r):
P sBSA = 1
I f0
× dI f
dt
× r
2
(2)
Endothelial glycocalyx imaging by electron micro-
scopy. Following real-time structural measurements of
glycocalyx and vessel permeability in vivo, vessels were
then perfused with albumin-free Alcian Blue-Ringer
solution (Alcian Blue 8GX, A5268, Sigma) as previously
described (Salmon et al. 2009) for 5 min (Fig. 2F).
Superfusate was then switched from warm Ringer
solution to ice-cold glutaraldehyde (2.5%) for 5 min to
achievemesentery stiffening indicating successful fixation.
Micropipettes were then removed, the mesenteric panel
containing the preserved vessel dissected away from the
surrounding gut, rinsed and then stored in glutaraldehyde
at 4°C. Specimens were post fixed using 1% osmium
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tetroxide, 1% lanthanum chloride and saturated uranyl
acetate on ice, and then processed and embedded into
resin. The cannulation site in the microvessel studied
in vivo was identified, and the block was trimmed until
100 nm sections containing the previously studied portion
of mesenteric microvessel were cut, mounted on piloform
covered slot grids, and imaged with 120 keV transmission
electron microscopy (Tecnai T12 with an Eagle camera
(FEI)) (Fig. 2Fc).
Electron micrographs were analysed using Adobe
Photoshop software. Images from eight points evenly
spaced around the lumen were assessed to quantify
glycocalyx depth in each of these regions. The depth
was assessed at 20 points for each high power image
by measuring the anatomical distance from the luminal
phospholipidbilayer to the furthestpointof theglycocalyx;
perpendicular measurements were ensured by only using
images where the phospholipid bilayer was visible as two
distinct layers. This was performed by initially overlaying
a grid, and depth was measured at any point where the
visible phospholipid bilayer crossed vertical or horizontal
lines (depending on the orientation of the image). Sample
groups were blinded before analysis, and measurements
performed at points where endothelial cell membranes
touched the overlaid gridlines to eliminate potential sub-
jective interpretations.
Hydraulic conductivity and reflection coefficient
measurement. In separate experiments, we used the
Landis–Michel micro-occlusion technique as previously
described to measure permeability coefficients hydraulic
conductivity (Lp) and the reflection coefficient to albumin
(σBSA) in intact microvessels in vivo (Salmon et al. 2009).
In the steady state the following holds (Michel &
Phillips, 1987):
J v
A
= L p(P − σ2c) (3)
Individual mesenteric microvessels were exposed,
cannulated with a single-lumen bevelled micropipette,
and perfusedwith 4%BSA–Ringer solution supplemented
with low-density rat erythrocytes (as flow markers and
source of sphingosine-1-phosphate (S1P)) at 60, 80
or 100 cmH2O. Vessels were intermittently and briefly
occluded with a fine glass rod. Fluid filtration rate per unit
area (Jv/A) was calculated from the rate of erythrocyte
movement towards the occluder and the cross-sectional
area of the vessel. Lp (×10−7 cm s−1 cmH2O−1) was
calculated from the slope of the relationship between
filtration rate and applied pressure, and the measured
effective oncotic pressure difference (σπ) from the
abscissal intercept. The ideal oncotic pressure of this
perfusate (πc) was calculated empirically (Bates, 1998).
The reflection coefficient was subsequently calculated
from the relation (Michel & Phillips, 1987):
σ = √(σπ/πc) (4)
Measurements were repeated before and after perfusion
with neuraminidase for 20–25 min, matching apparent
solute permeability experiments described above.
Determination of true diffusive solute permeability.
Convective and diffusive fluxes of albumin contribute to
the apparent solute permeability coefficient for albumin
(PsBSA). The relative importance of these processes were
discriminated using the recast form of the Patlak equation
derived by Curry (Curry, 1984) and as subsequently
expressed by Fu et al. (1998):
P s = Pd Pe
(ePe − 1) + L p(1 − σ)Peff (5)
where
Pe = L p(1 − σ)Peff
Pd
(6)
and
Peff = P − σalbalb (7)
where Pd represents the true solute diffusive permeability
coefficient for albumin across the vascular wall, and Pe is
the Peclet number (ratio of convective to diffusive flux).
Statistical analysis. All statistics were calculated using
Prism (GraphPad) software. Statistical significance was
considered positive when a P value of < 0.05 had
been demonstrated. Unless otherwise expressed, all data
are presented as mean ± standard error of the mean
(SEM). All n values represent the number of animals
used unless otherwise stated. Two-sided parametric tests
were employed for analysis of true value estimates of
glycocalyx parameters and PsBSA in vivo, as well as
glycocalyx depth measured from electron micrographs,
and the following statistical tests were employed: Pearson’s
rank for examination of correlation, paired t test, two-way
ANOVA, and one-way ANOVA were used for paired
experiments; unpaired t tests were used for unpaired
comparisons. All post hoc analyses used Bonferroni
post-tests
Results
Endothelial glycocalyx. Estimates of endothelial
glycocalyx depth made in vessels perfused with R18
and FITC-WGA using the FWHM method yielded
significantly higher measurements (1507 ± 136.9 nm,
n = 10) than those determined in the same vessels using
the peak to peak method of analysis (243.6 ± 22.44 nm,
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n = 10) (P < 0.001, paired t test; Fig. 3A). Using peak to
peak measurements the fraction of vessel wall yielding
positively resolvable glycocalyx measurements was
0.77 ± 0.04 (n = 10) and the mean peak If of FITC-WGA
across vessel walls was 176.4 ± 21.17 (n = 10). As the
peak If of the FITC-WGA signal increased, the paired
peak to peak depth of endothelial glycocalyx significantly
decreased, indicating that the peak If of FITC-WGA may
be influencing the anatomical location of the peak If of
R18, thereby resulting in a reduction in peak to peak
endothelial glycocalyx depth estimates (P < 0.05 by
Pearson’s correlation, r = −0.6975; Fig. 3B).
Endothelial glycocalyx depth measured in vivo using
both analysis methods (peak to peak and FWHM)
were compared with the depth of endothelial glycocalyx
measured at the same anatomical site of the same
vessel ex vivo from paired electron micrographs. Paired
comparisons demonstrated that endothelial glycocalyx
depth estimated with FWHM (1376 ± 99.77 nm, n = 5)
(Fig. 3C) and peak to peak (243.6± 22.44, n= 5) (Fig. 3D)
techniques both yielded significantly greater estimates of
depth than that estimated from paired electron micro-
graphs (78.09 ± 16.16 nm, n = 15) (P < 0.001,
paired t test). Endothelial glycocalyx depth measurements
were therefore 3.1- to 17.6-fold greater using confocal
microscopy in vivo than measurements at the same site
using electron microscopy ex vivo, with the broad range
dependent on the method used to analyse the confocal
microscopy images.
Measurements of glycocalyx depth for TRITC-WGA
and TMA-DPH peak to peak (622.7 ± 67.18 nm n = 5)
methods were, on average, significantly greater than the
previous depth estimates for FITC-WGA and R18 peak
to peak (231.4 ± 24.4 nm, n = 6, P < 0.001 by
unpaired t test) (Fig. 3E). Fractional coverage by resolvable
endothelial glycocalyx was not significantly different
using the two sets of fluorescent labels (TMA-DPH,
TRITC-WGA: 0.7867 ± 0.03851, n = 5; R18, FITC-WGA:
0.7028 ± 0.04291, n = 6) (P > 0.05 unpaired t test)
(Fig. 3F). Peak fluorescence intensity measurements were
also not significantly different between TRITC-WGA
(269.0 ± 109.5 greyscale units n = 5) and FITC-WGA
(123.6± 22.30 n= 6 greyscale units) (P> 0.05 unpaired t
test) (Fig. 3G).Unlike the significant relationbetween end-
othelial glycocalyx depth measured with the peak to peak
method and the peak If of FITC-WGA signal, there was
no significant relation between peak to peak determined
glycocalyx depth and the peak If of TRITC-WGA signal
(r = 0.29, P > 0.5 Pearson’s correlation).
Apparent solute permeability. To test the assumption of a
linear relationship between the number of Alexa 488-BSA
molecules in a perfused vessel with the mean If measured
in that same vessel in vivo, individual vessels were
imaged during consecutive perfusion with the following
concentrations of Alexa 488 BSA: 0, 0.003, 0.015, 0.03,
0.15 and 0.3 mg ml−1 of Alexa 488 BSA. There was
a significant linear relationship between the number of
Alexa Fluor 488 BSAmolecules and the mean If measured
within the perfused vessel (r2 = 0.9916, P < 0.0001,
Pearson’s correlation) (Fig. 4A and B). There was no
significant difference between PsBSA estimates made using
these different concentrations of Alexa 488 BSA in the
samemicrovessel (P>0.05byone-wayANOVA) (Fig. 4C).
Importance of endothelial glycocalyx sialic acids. To
determine whether endothelial glycocalyx sialic acids
contribute to endothelial glycocalyx structure and vessel
wall permeability, endothelial glycocalyx parameters and
solute permeability were measured in individual vessels
before and after (or with and without) disruption of
terminal sialic acids by perfusion with neuraminidase.
With the peak to peak method of analysis, there was no
significant difference between glycocalyx depth at base-
line (243.6 ± 22.44 nm, n = 10) and that measured
after 20 min of treatment with vehicle (231.4 ± 24.4 nm,
n = 6) (P > 0.05, two-way ANOVA Bonferroni
post hoc analysis) (Fig. 5A), but glycocalyx depth was
significantly reduced within single vessels after 20 min
of treatment with neuraminidase (185.0 ± 32.78 nm)
when compared to baseline (288.9 ± 28.74 nm)
(P < 0.01, n = 5, two-way ANOVA Bonferroni post
hoc analysis) (Fig. 5B). The technique with the peak
to peak method of analysis was sufficiently sensitive to
detect changes in endothelial glycocalyx depth in unpaired
comparisons of vehicle- or neuraminidase-perfused
vessels labelled with TRITC-WGA and TMA-DPH (rather
than FITC-WGA and R18, as described above) (vehicle
treatment: 622.7 ± 67.18 nm; neuraminidase treatment:
386.3 ± 10.82 nm; P < 0.05, unpaired t test) (Fig. 5C).
Removal of sialic acid residues with 20min of treatment
with neuraminidase also reduced the depth of end-
othelial glycocalyx as determined by the FWHM method
of analysis (1646 ± 352.6 nm, n = 5, at baseline;
1223 ± 199.4 nm, n = 5, after neuraminidase) (P < 0.05,
n = 5, two-way ANOVA Bonferroni post hoc analysis),
with no significant change in endothelial glycocalyx depth
as determined by the FWHM method when vessels
were treated with vehicle (1479 ± 68.81 nm) compared
to baseline (1355 ± 84.03 nm) (P > 0.05, two-way
ANOVA Bonferroni post hoc analysis) (Fig. 5D and E).
Unpaired comparisons (TRITC-WGA and TMA-DPH)
of the FWHM measure of glycocalyx depth did not
have sufficient discrimination to demonstrate a significant
reduction in glycocalyx depth following treatment with
neuraminidase (1492 ± 116.8 nm) when compared to
vehicle treated control (1265 ± 150.5 nm) (P > 0.05 by
unpaired t test) (Fig. 5F).
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Figure 3. Endothelial glycocalyx depth in an individual vessel varies by more than an order of
magnitude, according to the imaging and analysis method
A, microvessels were imaged immediately after perfusion with FITC-WGA (glycocalyx) and R18 (cell membrane).
A line was drawn across the full diameter of the vessel and the depth of the endothelial glycocalyx estimated
from: the full width measured at the point of half-maximal fluorescence intensity of FITC-WGA (FWHM); and the
anatomical distance between peak signal from R18 (cell membrane) and FITC-WGA (sialic acids within endothelial
glycocalyx) (peak to peak). FWHM analysis generated significantly higher values of glycocalyx depth than peak
to peak analysis (∗∗∗P < 0.001 paired t test). B, the depth of the glycocalyx (peak to peak method) (y-axis) was
inversely related to the peak fluorescence intensity (If) of FITC-WGA (x-axis) (r = −0.50, P < 0.05 Pearson’s
correlation). C, full-width half-maximum (FWHM) measurements of endothelial glycocalyx depth made from
confocal microscopy (CM) images were significantly greater than subsequent depth measurements of Alcian
Blue-labelled endothelial glycocalyx imaged with electron microscopy (EM) in the same vessel (∗∗∗P < 0.001 paired
t test). D, peak to peak measurements of endothelial glycocalyx depth from confocal microscopy (CM) images were
also significantly greater than measurements of Alcian Blue-labelled endothelial glycocalyx depth measurements
from electron microscopy (EM) in the same vessel (∗∗∗P < 0.001 paired t test). E, glycocalyx depth measurements
made in TMA-DPH and TRITC-WGA-labelled vessels by the peak to peak method are significantly greater than
peak-to-peak-determined endothelial glycocalyx depth measurements made in R18 and FITC-WGA-labelled vessels
(n = 6) (∗∗∗P < 0.001 unpaired t test). There is no significant difference between fractional glycocalyx cover (F)
or peak WGA fluorescence intensity (If) (G) in TRITC-WGA-labelled vessels and FITC-WGA-labelled vessels (all
non-significant (ns), P > 0.05 unpaired t test).
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The fluorescence intensity of FITC-WGA (If) was not
significantly altered after perfusion for 20 min with
vehicle (123.6 ± 22.30, n = 6) when compared to
that measured at baseline (176.4 ± 21.17, n = 10)
(P > 0.05, two-way ANOVA Bonferroni post hoc analysis)
(Fig. 5G), but was significantly reduced following 20 min
of neuraminidase perfusion (124.9 ± 13.53) when
compared to that imaged at baseline (460.9 ± 48.21)
(n = 5, P < 0.001, two-way ANOVA Bonferroni post hoc
analysis) (Fig. 5H). Unpaired comparisons of peak If of
TRITC-WGA did not have sufficient discrimination to
demonstrate a statistically significant change to glycocalyx
staining intensity following treatmentwithneuraminidase
(95.63± 24.53 nm) when compared to the vehicle-treated
control (269.0 ± 109.5 nm) (P > 0.05 by unpaired t test)
(Fig. 5I).
The proportion of vessels with a glycocalyx depth
greater than zero (fractional coverage), determined using
the peak to peak method, was unchanged from baseline
coverage (0.7650 ± 0.02563, n = 10) after perfusion of
vehicle (0.7028 ± 0.04291, n = 6) (P > 0.05, two-way
ANOVA Bonferroni post hoc analysis), and likewise was
unchanged before (0.8500 ± 0.07397, n = 5) and
after perfusion with neuraminidase (0.8167 ± 0.05603,
n = 5) (P > 0.05, two-way ANOVA Bonferroni post hoc
analysis) (Fig. 5J and K). Unpaired comparisons (using
TRITC-WGA and TMA-DPH) did reveal a significant
reduction in glycocalyx fractional coverage following
neuraminidase treatment (0.57 ± 0.07) when compared
to the vehicle-treated control (0.79 ± 0.04) (P < 0.05 by
unpaired t test) (Fig. 5L).
Measurement of endothelial glycocalyx depth within
electron micrographs revealed a significant reduction in
glycocalyx depth for vessels treated with neuraminidase
(40.01 ± 7.317 nm, n = 7) when compared to
vessels treated with vehicle alone (78.09 ± 16.16 nm,
n = 5) (P < 0.05, by unpaired t test) (Fig. 5M). The
depth of the endothelial glycocalyx determined in vivo
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Figure 4. Imaging and analysis of solute permeability in vivo
A, the mean fluorescence intensity of Alexa Fluor 488-conjugated BSA (If: y-axis) was measured and quantified
within a cannulated and perfused microvessel in vivo, and plotted against the concentration of Alexa Fluor
488-conjugated BSA being perfused (x-axis). The measured If is linearly related to the concentration of Alexa
Fluor 488-conjugated BSA being perfused (r2 = 0.9916, P < 0.0001 Pearson’s correlation). B, an expanded plot
of the lower range of If vs. Alexa Fluor 488-conjugated BSA concentration data, demonstrating that this linear
relation holds at the range of low concentrations of Alexa Fluor 488-conjugated BSA used in solute permeability
experiments (0.03 mg ml−1) C, PsBSA was calculated in the same perfused microvessel in vivo perfused with
different concentrations of Alexa Fluor 488-conjugated BSA. There was no significant difference between the
PsBSA values calculated from the If for each of these perfusates (ns, P = 0.9404, one-way ANOVA).
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Figure 5. Disruption of sialic acids reduces endothelial glycocalyx depth and coverage
Endothelial glycocalyx parameters were determined in vessels with sialic acid disruption achieved by 20 min
perfusion with 40 mg ml−1 BSA supplemented with 2 U ml−1 neuraminidase (filled triangles), or in control vessels
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perfused with 40 mg ml−1 BSA vehicle alone (baseline: filled circles; vehicle perfusion; filled squares). Glycocalyx
depth determined using the peak to peak method of analysis was no different before and after perfusion with
vehicle (A), but was significantly reduced after neuramindase perfusion (B), (ns: P > 0.05; ∗∗P < 0.01, two-way
ANOVA with Bonferroni post hoc analysis). This neuraminidase-induced reduction in peak-to-peak-determined
measurements of endothelial glycocalyx depth was reproduced in unpaired experiments (C), in which endothelial
glycocalyx depth was determined once only, after earlier measurements of solute permeability in the same vessel
during perfusion with either 40 mg ml−1 BSA vehicle alone (filled squares) or 40 mg ml−1 BSA supplemented
with 2 U ml−1 neuraminidase (filled triangles) (∗P < 0.05, unpaired t test). Likewise, glycocalyx depth determined
with the full-width half-maximum (FWHM) method was unaltered by perfusion with vehicle solution (D), but was
significantly reduced after neuraminidase perfusion (E) (ns: P > 0.05; ∗∗P < 0.01, two-way ANOVA with Bonferroni
post hoc analysis). However, in separate measurements in which endothelial glycocalyx depth was measured only
once by the FWHM after initial solute permeability measurements during perfusion with either 40 mg ml−1 BSA
vehicle alone (filled squares) or 40 mg ml−1 BSA supplemented with 2 U ml−1 neuraminidase (filled triangles), no
significant difference was determined (ns, P > 0.05, unpaired t test) (F). Identical results (as for FWHM) were also
obtained when determining the peak If of WGA-labelled endothelial glycocalyx in paired (G and H; ns: P > 0.05;
∗∗P < 0.01, two-way ANOVA with Bonferroni post hoc analysis) and unpaired (I; ns, P > 0.05, unpaired t test)
experiments. The fractional coverage of the vessel wall with endothelial glycocalyx resolvable with the peak to
peak method of analysis was no different before and after perfusion with either vehicle or neuraminidase (J and
K; ns: P > 0.05, two-way ANOVA with Bonferroni post hoc analysis), but a significant reduction was observed
after neuraminidase perfusion in unpaired experiments (L; ∗P < 0.05, unpaired t test). Endothelial glycocalyx depth
measured in electron micrographs was significantly lower in neuramindase-perfused vessels, as compared with
vehicle-perfused vessels (∗P < 0.05, unpaired t test) (M). There was a significant positive correlation between the
depth of endothelial glycocalyx determined in electron microscopy (EM) images with the depth of endothelial
glycocalyx determined by the peak to peak analysis method in confocal microscopy (CM) images in the same
vessel (N; r = 0.75, P < 0.05 Pearson correlation).
from peak to peak analysis demonstrated a significant
positive linear relationship to the depth estimates of
the endothelial glycocalyx in the same vessels using
electron micrographs (r = 0.7515, P < 0.05, Pearson’s
correlation, 9 pairs) (Fig. 5N). However, none of the
other measurements of endothelial glycocalyx parameters
obtained from confocal microscopy images (peak If,
fractional coverage) correlated with the endothelial
glycocalyx depthmeasurements from electronmicroscopy
images (FWHM: r=0.1362,n=9pairs,P>0.05Pearson’s
correlation; peak If: r = −0.5184, n = 9 pairs, P > 0.05
Pearson’s correlation; fractional coverage: r = −0.2734,
n = 9 pairs, P > 0.05 Pearson’s correlation).
Treatment of perfused microvessels with vehicle
solution for 20–25 min did not significantly alter
PsBSA (from (4.0 ± 0.43) × 10−6 cm s−1 to
(2.6± 0.44)× 10−6 cm s−1; n= 5 pairs; P> 0.05, two-way
ANOVA with Bonferroni’s correction), but disruption of
sialic acids with neuraminidase treatment did significantly
increase PsBSA 6.8-fold (from (3.5 ± 1.0) × 10−6 cm s−1
to (23.8 ± 8.3) × 10−6 cm s−1; n = 4 pairs; P < 0.001
by two-way ANOVA) (Fig. 6A). The rise in permeability
in response to neuraminidase treatment was progressive
and linear (r2 = 0.9216; P < 0.01, Pearson’s correlation)
(Fig. 6B).Therewas a significant inverse linear relationship
between PsBSA and endothelial glycocalyx fractional
coverage in the same vessels in neuraminidase-treated
and vehicle-treated vessels (r = −0.731, n = 9 pairs,
P < 0.05 Pearson’s correlation) (Fig. 6C). Likewise
there was an inverse relationship between PsBSA and
endothelial glycocalyx depth as assessed by the peak
to peak analysis of TRITC-WGA in the same vessels
in neuraminidase-treated and vehicle-treated vessels,
(r = −0.80, P < 0.05 by Spearman’s correlation) but this
relationshipwas not linear (best fit: single one-phase decay
curve; depth = 330 nm + 607 nm × e−0.38×Ps) (Fig. 6D).
Over the same time course, disruption of sialic
acids with neuraminidase treatment also significantly
increased hydraulic conductivity by 1.9-fold (baseline:
(1.39 ± 0.32) × 10−7 cm s−1 cmH2O−1; neuraminidase:
(2.68 ± 0.81) × 10−7 cm s−1 cmH2O−1; n = 7 pairs;
P < 0.05, Wilcoxon) (Fig. 6E) and significantly
reduced the reflection coefficient (baseline: 0.96 ± 0.01;
neuraminidase: 0.87 ± 0.03; n = 7 pairs, P < 0.05, paired
t test) (Fig. 6F).
Usingmeasured and calculated parameter values (PsBSA,
Lp, σ, πBSA) from these experiments, and calculating the
Peclet number for these experiments, true diffusive BSA
solute permeability coefficient values (Pd) were 7-fold
and significantly increased by disruption of sialic acids by
neuraminidase treatment (3.38× 10−6 cm s−1 under base-
line conditions; 2.41 × 10−5 cm s−1 after neuraminidase
treatment; P < 0.001, unpaired t test) (Fig. 6G).
Discussion
In this study we have successfully developed methods
for paired, real-time, direct in vivo assessment of end-
othelial glycocalyx structure anddependentmicrovascular
function (permeability). These techniques demonstrate
that measurements of the depth of endothelial glycocalyx
are highly dependent on the labelling, detection and
analysis methods employed, and vary by more than
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 6. Disruption of sialic acids increases microvascular permeability to water and albumin
A, apparent solute permeability to albumin (PsBSA) was measured in microvessels before (baseline) and 20–25 min
after (treatment) perfusion with either vehicle (filled bars) or neuraminidase (open bars). Sialic acid disruption
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with neuraminidase perfusion significantly increased PsBSA (∗P < 0.05, two-way ANOVA post hoc Bonferroni
analysis), with no significant change in PsBSA in vehicle-perfused control vessels (ns, P > 0.05, two-way ANOVA
post hoc Bonferroni analysis). B, PsBSA increased progressively over time during neuraminidase perfusion (filled
triangles), but remained unaltered during vehicle perfusion (filled squares). A significant increase in PsBSA was
noted after 15–20 min treatment with neuraminidase, matching the time course of neuraminidase-induced end-
othelial glycocalyx disruption (∗∗∗P < 0.001, two-way ANOVA, Bonferroni post hoc analysis). A significant inverse
correlation was noted between PsBSA and fractional coverage by resolvable endothelial glycocalyx determined with
the peak to peak method (C) (r = −0.73, P < 0.05 Pearson correlation). A significant relation between PsBSA and
endothelial glycocalyx depth determined with the peak to peak method was best described by a single one-phase
decay curve with a relationship of depth = 330 nm + 607 nm × e−0.38×Ps (D). Microvessel hydraulic conductivity
(LP) was significantly increased after sialic acid disruption with 20–25 min perfusion with neuraminidase (filled
triangles) compared with baseline measurements in the same vessel (filled circles) (∗P < 0.05, Wilcoxon) (E).
Microvessel reflection coefficient to albumin was significantly reduced after sialic acid disruption with 20–25 min
perfusion with neuraminidase (filled triangles) compared with baseline measurements in the same vessel (filled
circles) (∗P < 0.05, Wilcoxon) (F). There was a significant increase in true diffusive solute permeability to albumin
after sialic acid disruption with neuraminidase (∗P < 0.001, unpaired t test) (G).
an order of magnitude. Highest values are obtained by
full-widthhalf-maximumanalysis offluorescently labelled
WGA-lectin binding to the endothelial glycocalyx, and
lowest values are obtained from electron micrographs
of Alcian Blue-labelled endothelial glycocalyx from the
same vessel. Estimating the anatomical distance between
peak signals from endothelial glycocalyx and endothelial
cell membrane labels with distinct fluorescence emission
spectra provides the most sensitive and reliable measure
of endothelial glycocalyx depth. Sialic acid residues within
the endothelial glycocalyx regulate glycocalyx structure,
as well as the permeability of the vessel wall to both
water and albumin. Neuraminidase-induced changes in
glycocalyx structure (by fluorescence and electron micro-
scopy) correlatedwith changes in transvascular solute flux.
Sialic acids cap a range of glycoproteins within the end-
othelial glycocalyx (e.g.Varki, 2008) andarepresent athigh
density on the endothelial cell surface (<50 × 106 μm−2,
Born & Palinski, 1989, including in human microvessels,
Tatsuzuki et al. 2009), and are potentially found at
increased density at the endothelial cell surface adjacent
to the dominant route for water and solute flux across
the vessel wall: interendothelial clefts (Bai &Wang, 2014).
The current studies demonstrate that disruption of sialic
acid residues within the endothelial glycocalyx reduces the
degree of reflection of albumin by the microvessel wall,
and increases the conductance of water, and therefore
sialic acid residues within the endothelial glycocalyx are
principal regulators of microvessel permeability.
These findings are in direct conflict with the only other
investigation of the effect of sialic acid disruption on
true permeability coefficients in vivo (Mason et al. 1977),
in which neuraminidase had no effect on mesenteric
microvessel hydraulic conductivity. Whilst it is possible
that species differences (frog vs. rat) account for this
difference, the highly conserved nature of endothelial
sialic acid expression (Aamelfot et al. 2014) argues
against this possibility. We suggest that it is more likely
that temperature differences (frog 15°C; rat 37°C)
permit greater enzyme activity and hence greater degree
of sialic acid disruption in the current study, thereby
revealing an important role of sialic acids in regulating
permeability. The previous study in frogs did not perform
paired labelling of glycocalyx or other ultra-structural
components, and thus active changes in structure assumed
to be brought about by neuraminidasewere not confirmed
(Mason et al. 1977) as they have been here.
Other evidence supporting the concept of sialic acids
regulating microvascular permeability arise from systems
in which the measures of permeability coefficients are
confounded by the model used or by unregulated
variables. For example, disruption of endothelial
glycocalyx sialic acids with neuraminidase was shown to
increase permeability and reduce glycocalyx depth of end-
othelial cells in vitro (Singh et al. 2007; Cioffi et al. 2012).
Whilst cultured endothelial cells display permeability
coefficients that are orders ofmagnitude greater than those
observed in intact vessels in vivo (Curry, 2005), andpossess
an endothelial glycocalyx that differs substantially from
that observed on intact vessels (Chappell et al. 2009), these
findings are consistent with the demonstrated importance
of sialic acids in regulating multiple permeability
coefficients in vivo in the current report. Investigations
into the effects of neuraminidase on water and albumin
flux in other microvessel beds support our findings
that true microvessel wall permeability coefficients are
regulated by sialic acid residues. One such study observed
alveolar oedema formationwithin isolated-perfused lungs
from rats treated with neuraminidase (0.5 U ml−1 for
30 min) demonstrating an 8-fold increase in trans-
vascular perfusate flux (calculated from the change in
organ weight at different perfusion pressures) indicating
that sialoglycoproteins expressed within the endothelial
glycocalyx of pulmonary microvessel beds may influence
solute and water flux (Cioffi et al. 2012). Since sialic acids
also regulate glycocalyx-mediated mechanotransduction
(Tarbell & Pahakis, 2006) and consequent vessel dilatation
(Kumagai et al. 2009), observed increases in solute or
water flux following neuraminidase treatment (Cioffi
et al. 2012; Salmon et al. 2012) may represent a
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vasodilatation-induced increase in the hydrostatic forces
driving solute and water flux rather than a true change
in the permeability of the vessel wall. The current studies
confirm that, over and above regulating vessel diameter
and hence the magnitude of Starling forces driving solute
and fluid flux, sialic acids also regulate the permeability of
microvessel walls.
There are a number of biophysical and biochemical
mechanisms through which sialic acids may regulate
microvascular permeability. The contribution of the end-
othelial glycocalyx to hydraulic permeability is thought to
be imparted largely through glycocalyx depth (Adamson,
1990), with a reduction in glycocalyx thickness sufficient
to explain increased hydraulic conductivity, as observed
in response to sialic acid disruption here. The endothelial
glycocalyxhasbeencalculated to contribute approximately
60%to thehydraulic resistanceof the vesselwall (Adamson
et al. 2004).The2-fold increase inhydraulic conductivity
following neuraminidase treatment is comparable to the
2.5-fold increase in hydraulic conductivity following
pronase treatment of frog mesenteric microvessels
(Adamson, 1990), and also similar to the 2.3-fold
increase in hydraulic conductivity observed in rats
with spontaneous proteinuric chronic kidney disease
and reduced glycocalyx depth (Salmon et al. 2012).
The relationship between glycocalyx depth and albumin
permeability has been less clear: the non-linear relation
between these parameters indicated here (Fig. 6D)
illustrates one possible aspect of that relationship. The
presence of glycocalyx after neuraminidase treatment
with a reduction in thickness of a similar relative level
(60% for confocal, 50% for electron microscopy) suggests
that the glycocalyx needs to reach a minimal depth
before being able to impede albumin flux. Alternative
explanations include a potential change in glycocalyx
coverage in critical permeability-determining regions,
such as in microdomains overlying interendothelial clefts.
Furthermore, since other structural and biological aspects
of the glycocalyx (such as 3-D ultrastructure and electrical
charge) have not been assessed with these techniques,
parameters other than depth and spatial distribution
may also impact on the relationship between glycocalyx
structure and albumin permeability. This could be further
investigated with more information on the structure of
the glycocalyx, such as that generated using complex
staining techniques (Arkill et al. 2011) to be able to build
testable models of how the glycocalyx regulates albumin
permeability.
The observed reduction in endothelial glycocalyx
thickness is unlikely, however, to explain the observed
reduction in reflection coefficient. Molecules are reflected
back into the vessel lumen during convective drag
because the functional pore aperture, determined by the
combinationof steric and electrochemical pore properties,
is too small to allow large solutemolecules (such as BSA) to
pass. The ordered lattice-like structure of the endothelial
glycocalyx imparts efficient molecular sieving properties
(Arkill et al. 2011), with the arrangement, dimensions and
charge of the individual fibres of the lattice all dictating
the efficiency with which solutes are reflected back into
the vessel lumen under conditions of convective flux (Hu
et al. 2000; Squire et al. 2001; Weinbaum et al. 2003;
Arkill et al. 2011). Membrane-bound components of the
endothelial glycocalyx display the necessary quasi-ordered
arrangement to contribute to this ordered lattice (Squire
et al. 2001), raising the possibility that sialic acid-capped,
membrane-bound glycoproteins and/or proteoglycans
may be important in regulating the molecular sieving and
hence the reflection coefficient of microvessel walls. For
example, sialic acid-depleted glycoproteins may form a
pore that provides less resistance to the passage of albumin
molecules because of reduced net negative charge on
the fibres surrounding the pore, thereby facilitating the
passage of negatively charged albumin molecules through
the pore. However, removal of sialic acid residues did
not significantly alter the surface charge of endothelial
cells (Vargas et al. 1989), and hence the neuraminidase
effect observed here may be steric rather than electro-
chemical, through altering the shape, size or interactions
between sialic acid capped molecules that comprise the
pore. Combining the current structure–function studies
with glycan-specific electron dense labels (e.g. gold
particle-labelled lectins, Baldwin & Winlove, 1984) and
Fourier transformation analysis to investigate changes to
the ordered arrangement of sialic acid residues within the
endothelial glycocalyx may be informative in this regard.
Sialic acid disruptionmight also (or alternatively) result
in secondary changes within the endothelial glycocalyx,
thereby altering permeability coefficients. For example,
rearrangement or activation of glycocalyx-embedded
receptors or interendothelial cleft molecules such as
VE-cadherinmay follow sialic acid disruption (Geyer et al.
1999). However, reorganisation of the interendothelial
cleft molecules occurs hours after sialic acid disruption
(Cioffi et al. 2012), more slowly than both the increase
in permeability and the change in endothelial glycocalyx
measurements observed over minutes in these studies.
Directmodification of the endothelial glycocalyx therefore
appears to be a more likely explanation for the changes
in permeability measured here. Disrupting the inter-
action between sialoglycoprotein-based arginine residues
and albumin molecules may have reduced the adsorbed
fraction of albumin within the endothelial glycocalyx,
reducing albumin-dependent sphingosine-1-phosphate
signalling leading to active shedding of other glycocalyx
(Adamson et al. 2012, 2014; Curry et al. 2012; Curry
& Adamson, 2013; Zeng et al. 2013). However, these
secondary changes again point to an important role for
sialic acid residues within the endothelial glycocalyx in
regulating microvessel permeability.
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These simultaneous changes in microvessel
permeability and endothelial glycocalyx structure
have been revealed through novel techniques that permit
examination of microvessel permeability coefficients
as well as real-time confocal microscopy and post hoc
electron microscopy examinations of the endothelial
glycocalyx covering the same portion of the same vessel.
Neuraminidase-induced changes in the endothelial
glycocalyx structure identified with confocal microscopy
correlated with parallel changes in the endothelial
glycocalyx measured from electron micrographs of the
same portion of the same vessel in vivo. A number of
processing steps are required to visualise the endothelial
glycocalyx by electronmicroscopy, including albumin-free
perfusion prior to Alcian Blue labelling, glutaraldehyde
fixation and dehydration steps, each of which may
affect glycocalyx appearance in electron micrographs.
Nevertheless, the findings from the current report provide
confidence that, at least under the conditions reported
here, changes in the structure of the endothelial glycocalyx
observed by standard electron microscopy techniques
correlate well with both direct imaging of the endothelial
glycocalyx in vivo (i.e. pre-EM processing) and with the
function of the vessel wall.
The absolute value of endothelial glycocalyx depth
measurements with this method is within the range
reported by others using a variety of techniques (for
review see Curry & Adamson, 2012), but above the
theoretical maximum threshold depth compatible with
the demonstrated hydraulic conductivity of vessel walls
(Curry & Adamson, 2013). Importantly, different analysis
methods of the same lectin-labelled images generated a
6-fold range of glycocalyx depth measurements (FWHM
to peak to peakmethods), and the same analysis technique
using different membrane and glycocalyx labels (peak
to peak techniques) generated a 2.5-fold range of
glycocalyx depths. Even the lowest estimate of glycocalyx
depth from confocal images was 3-fold greater than
depth assessed from electron micrographs. Clearly the
method used to estimate glycocalyx depth has a large
impact on the absolute value of endothelial glycocalyx
depth reported, even when multiple assessments are
made on the same vessel under identical conditions.
This makes it difficult to compare studies using varied
methodologies to judge whether there are true differences
in the endothelial glycocalyx between different vessel beds.
These findings suggest that quantifying relative changes in
glycocalyx depth in response to individual experimental
manipulations under identical experimental conditions
may be more reliable than interpreting the absolute depth
of the endothelial glycocalyx from varied techniques.
Nevertheless, the peak to peak method, based on
the anatomical distance between the peak endothelial
plasmalemmal signal and the peak glycocalyx-bound
lectin signal, (1) enabled discrimination of
neuraminidase-induced changes in confocal-determined
glycocalyx depth measurements under paired and
unpaired conditions, (2) with different glycocalyx and
membrane labels, (3) correlated well with changes
in endothelial glycocalyx depth measured by electron
microscopy, and (4) correlated with changes in vessel
wall function, thereby proving the most sensitive
and reliable real-time in vivo method for quantifying
changes in the endothelial glycocalyx. The choice of
glycocalyx and endothelial cell membrane labels for these
peak to peak assessments included FITC-WGA/R18,
with demonstrated limitations including fluorescence
emission signal bleed through and interactions between
the magnitude of fluorescence signal and glycocalyx
depth. TRITC-WGA/TMA-DPH assessments did not
suffer from either of these theoretical or measurement
errors, but the variability of peak fluorescence signal was
greater and will benefit from assessment in larger sample
sizes. Peak to peak measurements were preferred over
full-width half-maximum measurements, as previous
studies have indicated the presence of lectin binding
to sialic acid residues on the abluminal side of the
endothelial cell (e.g.Oltean et al. 2015) that broaden the
resulting fluorescence signal to generate falsely elevated
estimates of ‘endothelial glycocalyx’ depth. Failing to
discriminate between luminal and abluminal surface
glycocalyx components may have contributed to some
of the higher values for glycocalyx depth reported in the
literature, particularly in the absence of simultaneous
imaging of the endothelial cell surface (Yen et al. 2012).
Full-width half-maximum, peak fluorescence intensity
and fractional coverage analysismethods were not capable
of discriminating neuraminidase-induced changes in
the endothelial glycocalyx reliably (e.g. in paired and
unpaired studies); none correlated with changes by
electron microscopy, and neither peak fluorescence
intensity or full-width half-maximum measurements
correlated with changes in solute permeability; indicating
that comparative assessment of glycocalyx signal relative
to the endothelial cell surface is an important facet of
measuring glycocalyx depth.
These direct labelling methods for quantifying the
endothelial glycocalyx are an important complement to
indirect methods of glycocalyx assessment, in which
the distance of a luminal tracer (electron-dense lipid
droplets, fluorescently labelled circulating molecules or
microparticles, circulating cells) from the vessel wall is
assumed to represent an impenetrable depth of end-
othelial glycocalyx. Many such methods need to take
into account partial permeation of the tracer into the
endothelial glycocalyx (Michel & Curry, 2009), as well
as the influence of the glycocalyx on the spatial profile
of substances flowing through the vessel (Pries et al.
1997). As such, changes in haemodynamics as well as
changes in the endothelial glycocalyx could impact on
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the distance of the tracer from the vessel wall, thereby
confounding the assumption that this distance represents
the depth of the endothelial glycocalyx. Stop-flow studies
(Haraldsson, 2014) and studies on small diameter vessels
(Damiano, 1998) have been employed to overcome
this confounding influence. Direct glycocalyx labelling
methods reported here complement the critical in vivo
assessments of glycocalyx-dependent vascular functions.
These considerations are also important because of the
recent spread of indirect methods of estimating end-
othelial glycocalyx depth into the clinical arena (Lee et al.
2014), using technologies that are not designed to directly
measure the anatomical location of the vessel wall and
therefore can only estimate a non-perfused boundary
region. Validation studies coupling these potentially
revolutionary clinically applicable methodologies with
direct assessment of the endothelial glycocalyx are
warranted.
Our study has a number of potential limitations.
Neuraminidase cleaves the O-glycosidic linkages between
the terminal neuraminic (sialic) acids and the subterminal
sugars (Cassidy et al. 1965), but almost all enzymatic
manipulations of endothelial glycocalyx components are
prone to direct but off-target enzymatic disruption of
other components of the endothelial glycocalyx (Tarbell,
2010).Neuraminidase removes<5%of other components
of the endothelial glycocalyx (Pahakis et al. 2007). Wheat
germ agglutinin lectin also labels N-acetyl-glucosamine
residues within various glycosaminoglycans, although
more than 60% of WGA-labelled structures are sialic
acids (Barker et al. 2004). Overall, the >95% specificity
of neuraminidase and >60% specificity of WGA for
sialic acid residues indicates that no more than 2% of the
observed reduction in WGA signal after neuraminidase
treatment is likely to be due to an effect on other
glycocalyx structures.
Three parameters of microvascular permeability were
measured in rat mesenteric microvessels under identical
experimental conditions before and after exposure
to neuraminidase, but true permeability coefficients
(hydraulic conductivity and reflection coefficient) were
measured in different vessels from those in which
measurements of endothelial glycocalyx were made. This
represents a technical limitation, since different micro-
scopes were required for confocal and light microscopy
studies, and it was not practical to maintain anaesthesia
and transport animals between rigs. Nevertheless
there is good concordance amongst the results, and
changes in apparent solute permeability in one set of
experiments are explained by the observed changes in
hydraulic conductivity and reflection coefficient observed
in parallel experiments. Of note, however, is that
despite this concordance the magnitude of the PsBSA
values reported here (2.8 × 10−6 cm s−1 under
normal and vehicle-treated conditions) is greater than
the 0.4 to 1.0 × 10−6 cm s−1 measured in rat
mesenteric microvessels by other researchers (Fu & Shen,
2004; Cai et al. 2012; Curry et al. 2012; Adamson
et al. 2014). In contrast, hydraulic conductivity values
(1.39 × 10−7 cm s−1 cmH2O−1) are in the range reported
previously (1.2–2.43 × 10−7 cm s−1 cmH2O−1; Kendall &
Michel, 1995; Michel & Kendall, 1997; Curry et al. 2003,
2012; Salmon et al. 2009) as are reflection coefficient values
(0.96; e.g. 0.94, Kendall & Michel, 1995). This suggests
that technical factors relating to the PsBSA experiments
may be responsible for these higher PsBSA values, such
as reduced S1P content of erythrocyte-free perfusate
in PsBSA and glycocalyx imaging studies (necessitated
by the use of narrow-lumen double-barrelled theta
pipettes in contrast to erythrocyte-containing perfusate
in hydraulic conductivity/reflection coefficient studies;
Curry et al. 2012), or an influence of the Alexa
488 label applied to BSA (as demonstrated for other
fluorescent labels; Bingaman et al. 2003). Low S1P
conditions may compromise glycocalyx and intercellular
junction integrity, affecting baseline permeability states,
and this hinders detailed biophysical interpretation of
sialic acid-regulated pathways for transvascular passage
of albumin.
The perfused single vessel methodology adopted here
has also been critiqued in the literature. However,
single vessel perfusion permeability techniques have been
described as the ‘squid giant axon’ of permeability studies
(Curry, 2005); the current report extends their utility to
real-time in vivo structure–function assessments of the
endothelial glycocalyx as a complement to the range of
othermicrovascular endothelial glycocalyx studies already
available or in development.
Given the widespread importance of the endothelial
glycocalyx for normal physiology and a broad number of
disease states, we have expanded the range of techniques
that permit direct studies of the structureof the endothelial
glycocalyx, as well as dependent microvascular functions.
Through these novel techniques, we demonstrate that
sialic acid residues within the endothelial glycocalyx are
critical regulators of microvascular permeability to both
water and albumin.
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